Endobrochites of specific genesis in patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 201s Year: 2004
Pulmonary arterial manifestation of systemic inflammation in patients with COPD Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010
Evolution of systemic response in patients with pulmonary sarcoidosis of different course of the disease during anti-inflammatory treatment Source: Annual Congress 2009 - Sarcoidosis in review Year: 2009
Pulmonary manifestations in adult patients with chronic granulomatous disease Source: Eur Respir J 2015; 45: 1613-1623 Year: 2015
CT patterns of pulmonary sarcoidosis are associated with prognosis and complication of chronic pulmonary aspergillosis or non-tuberculous mycobacteria Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage Year: 2019
Prevalence and low diagnostics of chronic non-specific pulmonary diseases among pulmonary TB patients Source: Annual Congress 2007 - Tuberculosis control in the penitentiary and civilian sector Year: 2007
Systemic inflammation and colonization in patients with clinically stable bronchiectasis Source: Eur Respir J 2007; 30: Suppl. 51, 528s Year: 2007
Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003
Severe lung involvement in systemic scleromyxoedema: a highly unusual finding Source: Eur Respir J 2002; 19: 976-979 Year: 2002
The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005
The profile of patients with pulmonary and extrapulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 312s Year: 2001
Methotrexate in the treatment of the chronic form of pulmonary and extra - pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004
Does concomitant extrapulmonary involvement changes characteristic features of pulmonary sarcoidosis? Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Allergic/invasive pulmonary aspergillosis in CGD (chronic granulomatous disease) patients Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection Year: 2009
Early diagnosis of invasive pulmonary aspergillus in patients with chronic obstructive pulmonary diseases: a case control study Source: International Congress 2019 – Airway infection in COPD Year: 2019
The study of pulmonary circulation in the patients with pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001
The link between systemic inflammation and pulmonary hypertension in patients with stable COPD Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005
Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19. Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021
Diffuse interstitial pneumonia and pulmonary hypertension: a novel manifestation of chronic granulomatous disease Source: Eur Respir J 2009; 33: 1498-1502 Year: 2009
Non-infectious pulmonary complications in immunocompromised (IC) patients. Associated pulmonary and systemic inflammatory response Source: Eur Respir J 2004; 24: Suppl. 48, 241s Year: 2004